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Incubations of (1 '1C]arachidonic acid (p"C]AA) with 
cell-free preparations from normal, clinically involved 
and uninvolved epidermis from psoriatic subjects re-
sulted in the formation of several radiolabeled metabo-
lites of the lipoxygenase pathway. The identities of the 
monohydroxy-ETEs and dihydroxy-ETEs (products of 
the 12-lipoxygenase and 5-lipoxygenase pathways) 
were determined by comparison with authentic stan-
dards of 12L-hydroxy-5,8,10,14-eicotetraenoic acid 
(12-HETE) and authentic 5S,12R-dihydroxy-6,8,10, 
14-eicosatetraenoic acid (LTR,) by thin-layer chroma-
tography in two solvent systems; by silicic acid column 
chromatography and by normal phase and straight 
phase high-pressure liquid chromatography. Activity of 
the enzymes which catalyze this transformation are lo-
calized in the soluble (105,000 g supernatant) fraction 
of the epidermal preparations. The activity of enzymes 
of both pathways were inhibited by 5,8,11,13-eicosate-
traynoic acid (ETY A) and nor-dihydroguaretic acid 
(NDGA), known inhibitors of the lipoxygenase and cy-
clooxygenase pathways. Transformation of [14C]AA into 
[ 1"C]L TB.-like metabolite by the soluble preparations 
from clinically involved psoriatic epidermis was signif-
icantly higher (p < 0.001) than from paired uninvolved 
soluble preparations or from soluble preparations from 
normal subjects. Furthermore, biosynthesis of L TB,.-
like metabolite by the uninvolved soluble preparation 
was significantly higher (p < 0.05) than preparations 
from normal epidermis. These results imply that the 
P"C]L TB,.-like metabolite biosynthesized by the clini-
cally involved soluble preparation was due at least in 
part to the increased activity of the Iesional enzymes 
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and not entirely due to possible intraepidermal infil-
trating neutrophils. Human epidermal preparations, 
therefore, contain enzymes which catalzye the transfor-
mation of labeled AA into labeled LTR1-like metabolite 
as well as into other yet unidentified dihydroxy-ETEs. 
Localization of a Soluble 5-lipoxygenase-like activity in 
the epidermis implies a possible role of the lipoxygenase 
products in the proliferative and inflammatory proc-
esses in this tissue. 
A marked increase in the endogenous levels of arachidonic 
acid (AA) and 12L-hydroxy-5,8,10,14-eicosatetraenoic acid (12-
HETE) was first reported in clinically involved epidermis of 
psoriasis by Hammarstriim et al [1]. This revelation prompted 
great interest and curiosity as to the possible contribution of 
products of the AA lipoxygenation on the pathogenesis of 
psoriasis. Consistent with the enhanced activity of the lipoxy-
genase pathway, Penneys et al (2) reported the inhibition of 
sheep vesicular gland cyclooxygenase activity by homogenates 
obtained from clinically involved psoriatic epidermis and Wo-
ronoff ring [3). This reduced metabolism of AA via the cycloox-
ygenase pathway, would in turn result in the accumulation of 
AA and possibly redirect its metabolism via the lipoxygenase 
pathway. 
Recently an elevated level of leukotriene B4 (L TB,1) was 
reported in extracts of chamber fluid from psoriatic plaque [ 4) 
suggesting the possible existence of a 5-lipoxygenase pathway 
in the clinically involved psoriatic epidermis. To rule out the 
possibility that the L TB,-like material observed in the clini-
cally involved areas of psoriatic skin was due solely to infiltrat-
ing neutrophils (known to biosynthesize L TB4 ) and to defi-
nitely establish the activity and the subcellular localization of 
the 5-lipoxygenase enzyme activity in human epidermis, we 
investigated the transformation of radiolabeled AA into radio-
labeled lipoxygenase products by cell -free enzyme preparations 
from normal human epidermis as well as from the uninvolved 
and the clinically involved epidermis of psoriatic subjects. 
MATERIALS AND METHODS 
[1 -"C]AA (58.0 mCi/ mmol) was obtained from Amersham Corpo-
ration, Arlington , Illinois. The radiolabeled fatty acid was purified by 
column chromatography on silicic acid (Silicar CC-4) using n-hexanej 
diethyl ether (9:1) as elut ing solvent as reported previously [5]. Unla-
beled AA was obtained from Lipid Organic Research, Elys ian , Minne-
sota. Purity (>90%) was verified by gas liquid chromatography (GLC). 
5S,12R-D ihydroxy-6,8,10,14-eicosatetraenoic ac id (LTB.,), which has 
been characterized by gas chromatograph-mass spectroscopy (GC-MS) , 
was generously supplied by Dr. Rokach of Merk Frosst (Pointe Claire, 
Canada) . 12-HETE was biosynthesized from the incubation of AA with 
human indomethacin-treated platelets and purified as reported by 
McGuire et al [6] . Purity was verified by high-pressure liquid chroma-
tography (HPLC). Nor-dihydroguaretic acid (NDGA) and 5.8,11,13-
eicosatetraynoic acid (ETY A), known inhibitors of cyclooxygenase and 
lipoxygenase pathways, were gifts from Dr. J ames Hamilton, Hoff-
mann-La Roche, Nutley, New J ersey. All reagents were of analytica l 
grade. 
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Skin Biopsies 
Whole epidermal biopsies of 0.4 mm thickness were taken from 
clinically involved areas of skin from 10 psoriatic subjects with a 
Castroviejo keratome blade a fter obtaining a signed informed consent 
form , which had previously been approved by t he University of Mich· 
igan Committee for Protection of Human Research. Specimens 0.2 mm 
t hic k were taken from uninvolved areas of the skin from the same 
psoriatic subjects. A few specimens from 2 subjects were also taken of 
t h e outer 0.2-mm section of the psoriatic plaque to provide an upper 
epidermal section (mainly stratum corneum and gra nulosum) and an 
inner 0.2-mm lower section (mainly stratum basale and spinosum). For 
controls, whole epidermal biopsy specimens of 0.2 mm thick ness were 
taken from each of 8 normal volunteers. Representative sections from 
these specimens were taken for histologic estimation of t hickness and 
the r e maining portions snap-frozen in liquid ni t rogen and stored at 
-70"C until homogenized and used for incubations. 
Preparation of Subcellular Fractions of Human /<..pidermis 
The frozen epidermal strips were minced with scissors on ice a nd 
t h e n h omogenized by a motor-driven Porter-Elvehjem glass homoge-
nizer in ice-cooled 0.05 M potassium phosphate buffer (pH 7.4) con-
taining 1mM EDTA. The unbroken cellula r debris were removed by 
filtrat ion of the crude homogenate through cheesecloth. A portion of 
t h e filtered crude homogenate was stored in a n ice bucket and used for 
inc ubations. The remaining homogenate was subjected to centrifuga-
t ion at 800 g for 12 min 4•c to remove the nuclear debris. The resul t ing 
s upernatant (H) fraction was subjected to fu rther centrifugation at 
105,000 g for 60 min to give 2 subcellular fractions: the high -speed 
105,000 g pellet (HSP) and high-speed supernatant (HSS) fraction. 
The protein contents of the crude homogenate (H) , t he resuspended 
pellet (HSP) , and the high-speed supernatant fraction (HSS) were 
determined by the method of Lowry eta! [7] with bovine albumin used 
as standard. 
Incubations of Subcellular Fractions with {1 -"C} AA 
The incubation procedure was similar to that previously adapted in 
o ur preceding studies [5] with subcellular fractions of murine kerati-
nocytes. Briefly, t he standard incubation mixture of 2 ml contained 
0.05 M potassium phosphate bu ffer (pH 7.4), calcium chloride (1.5 mM), 
(1 -'''C ]AA (5.8 X 105 cpm) and t he respective subcellular fractions 
(conta ining 1000- 2000 JJg protein). Reduced glutathione (GSH) was 
added to incubations with the HSS at a concentration of 1 mM . In 
preliminary incubations, transformation of ("C]AA acid into " C-Ia-
beled m etabolites were maximal at 15 min, as indicated in the preceding 
studies [5], and in t he range of subcellular proteins indicated above. 
The r eaction was terminated by t he addition of 4 vol of a solvent 
mixture of ethyl acetate:methanol:0.4 M citric acid (15:2:1, v/v). The 
14C-labeled extract was t ransferred in to a centrifuge tube, vortexed 
vigorously, and ce ntrifuged for 3 min at 12,000 g. The lower aqueous 
phase was frozen in a dry ice/acetone bath. The upper organic phase 
was carefully removed and dried under N2• Recovery of radioactivity 
by t his solvent extraction procedure was greater than 90%. 
Ide ntification of Radioactive Metabolites 
Thin-layer chromatography and autoradiography: In a typical sepa-
ration, approximately 25 JJg of authentic standards of L TB,, 12-HETE, 
a nd AA were eac h added to an aliquot of "C-labeled incubation extract. 
Each mixture was applied to an activated silica gel G coated on thin -
layer (TL) plates. Separation of the rad ioactive metabolites was by 
seria l development of the plates in 2 solvent systems: first in a 
mixture of ethyl acetate:2,2,4-trimethy lpentane:acetic acid:H20 
(82.5:37.5:15:75, v/v) and secondly, in a mixture of petroleum 
ether:diethyl ether:acetic acid (50:50:1, vfv), as reported previously 
(5] . The reference standards on the plates were visualized in a tank of 
iodine vapor. The plates were scan ned for radioactivity by a Packard 
Radiochromatogram Scanner, Model 7201. Additionally, the radioac-
t ive bands were visualized using autoradiographic procedures. Briefly, 
a utoradiographs were obtained by exposing TLC plates containing '''C-
labeled compounds to X-Omat x-ray film (Kodak). Plates were enclosed 
in a 2 ml -thick polyethylene bag, taped to the film and exposed for 7-
10 days, depending on the a mount of radioactiv ity on the plates. T he 
x-ray fi lm was developed in liqu id x-ray developer and fixed for 3 min 
in Rapid Fixer (Kodak). The radioactivity on t he plates was finally 
estimated by scraping 0.5-mm portions of t he gel into scintillat ion vials 
an d counting them in a scin t illation counter. 
Column chromatography on sil£cic acid: Approx imately 50% of the 
14C- Iabeled incubation extract was passed t hrough a glass column 
packed with 1 g of activated silicic ac id as reported by Borgeat and 
Samuelsson [8]. The radioactive materials were eluted with 30 ml of 
diethyl ether:hexane (25:75, vf v), diethyl ether:hexane (45:55, vfv) , and 
ethyl acetate, respectively. The three column effluents which respec-
t ively conta ined unmetabolized AA and nonpolar lipids in t he first. 
fraction, monohydroxy-ETEs in the second fraction, and t he dihy-
droxy-ETEs in the th ird ethyl acetate fraction were dried in separate 
vials under a rotary vacuum. 
High-pressure liquid chromatography: Prior to injection of each 
fraction separately into the HPLC instrument, AA and prostaglandin 
B2 (PGB2) (internal standards) were added to the first diethyl 
ether:hexane (25:75, v/v) fraction. To the second diethyl ether:hexane 
(45:55, v/v) fraction were added 12- HETE and PGB.,. Radioactivity in 
the first a nd second solvent effluents which no rm~lly contained ·AA 
and monohydroxy-ETEs, respectively, were separated on a normal 
phase (NP) HPLC Column. Briefly, each of the elu ted fraction s was 
dissolved in the mobile phase and injected in to the (NP) Altex JJI11 
porasi l-Sil column (10 JJm, 0.41 X 30 em) which was mounted on a 
Beckman-HPLC instrument (Model 324M). The chromatography was 
performed init ially with an isocratic solvent mixture A: hexa ne:acetic 
ac id (125:1 , v/ v) run for 10 min at flow rate of 1.0/ min. T his was 
followed by a linea r gradient from solvent A to 30% of solvent mixture 
B: hexane: isopropyl alcohol:acetic acid (100:0.8:0.5, v/v) run fo r 140 
min. The column with t he applied linear gradient was run at a flow 
rate of 2.0 ml/ min. The UV absorption of t he standards conta ined in 
the efnu ents was monitored cont inuously at 240 nm with a Beckman 
variable UV detector which was coupled to an Altex CRIA inteurator-
recorder. Fractions were also collected simultaneously eve ry mir~ute by 
a Gilson fraction collector (Model MFK Fractionator) which was 
connected to t he HPLC instrument. Aliquots of the collected fractions 
were taken and the radioactivity counted in a scin ti llation coun te r for 
the detection of 14C which coeluted with 12-HETE. 
T o identify the radioactivi ty that coeluted with L TB, on the sil icic 
acid column, standards of L TB, a nd PGB, (in ternal standard) were 
added to the eluted ethyl acetate fraction and dried under N2• A portion 
of this mixture was injected into a reverse phase HPLC packed with 
ultrasphere ODS-Column (25 X 0.46 em) as described previously !5]. 
The mixture of authentic L TB, and PGB2 was separated afte r t he 
application of t he mobile phase of metha nol:water:acetic acid 
(65:35:0.02, v/v ) which had previously been adjusted to pH 5.7. Column 
effluents were also collected by a Gilson fraction collect.o r and t he 14C 
counted in a scin t illation counter. 
A second portion of t he same ethyl acetate eluent which contained 
reference LTB.1, PGBz and 14C-labeled extract was methylated with 
diazomethane-ether solution and the resul t ing methyl esters of t he 14C-
Iabeled metaboli tes, LTB4 and PGB2 were injected in to a NP Altex 11 m 
porasil -Sil column (10 }Jm, 0.41 X 30 em) as described by Boraeat eta! 
[9]. The [14C]rnethyl esters, as well as authentic L TB, and PGB2 methyl 
esters, were eluted isoc ratically with a mixture of hexane: isopropyl 
alcoho\:acetlc ac1d (94:6:0.1, v/v) at a llow rate of 1 ml/ min . The UV 
absorpt ion of the compounds in the effluent fractions was monitored 
at 280 nm. Aliquots of fractions collected by t he Gilson fraction 
collector were assayed for radioactivity by counting in a scintillation 
counter. 
Statist.ical Methods 
Sta ndard statistical methods were used to determine the mean values 
and SEM. For comparison between the mean of the observations, 
Student's t-test was used. The probability (p) t hat statistical signifi -
cance was reached was determined at levels of 0.05 and below. 
RESULTS 
Identification of fl '1C] lipoxygenase Products of [l- 1''C] AA 
Formed by Subcellular Enzyme Preparations From Human. 
Epidermis 
Transformation. of [' ·'c]AA into ~-~ c-tabeled lipoxygenn~e prod-
ucts by subcellular fractions from clinically involved psoriatic 
epidermis: Results of an autoradiographic profile of incubations 
of [1-' ''C]AA with the subcellular fractions prepared from the 
clinically involved psoriatic epidermis is shown in Fig 1. Several 
14C-Iabeled metabolites of the lipoxygenase pathway (monohy-
droxy- and dihydroxy-ETEs) were formed when [' ·'C]AA was 
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FIG 1. Autoradiograph of TLCs of f"CJAA incubations with sub-
cellular preparations from psoriatic epidermis. Homogenates, HS 
(105,000 g) supernatants and HS (105,000 g) pellet fractions (1100 11g 
protein) from clinically involved epidermis were suspended in phos-
phate buffer (0.05 M) and incubated, respectively, with [1-"C))AA (5.8 
x 10'' cpm) and calcium chloride (1.5 mM) at 37' C for 15 min. HS 
(105,000 g) supernatants were incubated additionally with GSH (1.0 
mM). Authentic standards of 12-HETE and L TB4 were added respec-
tively to the 14C incubation ext racts and subjected to chromatography 
on TLC plates and to autoradiography as described under Materials 
and Methods. Lane 1 (far-left) shows the result of an incubation of 
["C]AA with platelet suspension containing indomethacin (20 11M). 
Formation of 12-HETE by platelets served as a control for this lipox-
ygenase product. Lane 2 (near-left) represents "C metabolites formed 
by the incubation of l"C]AA with HSS fraction. Lane 3 (near-right) 
represents "C metabolites formed by the incubation of ["C]AA with 
homogenate fraction ; and Lane 4 (far-right) represents metabolites 
formed by the incubation of [' ''C]AA with HSP fraction. 
incubated with the crude homogenate (H) and the HSS frac-
tions. These include 1'1C-labeled metabolites as illustrated by 
the autoradiograms of both subcellular fractions . The autora-
diographic profile of the incubation of ['"C]AA with indometh-
acin-treated washed platelets was used in these experiments to 
maximize the generation of 12-HETE. It served as a control to 
indicate the position of 12-HETE on the TLC plate when 
compared to the incubations of [1'C]AA with epidermal subfrac-
tions. The platelet dark band of 12-HETE is shown on the left 
corner of Fig 1. The upper band of the two lower dark bands 
seen in the TLC of the two subce llular fractions of homogenate 
and 105,000 g comigrated with authentic L TB •. Visually, no 
major dark bands of ' ''C-labeled metabolites were djscernable 
in incubations of [1'C]AA with the HS pellet prepared from the 
psoriatic epidermis under the conditions of these experiments. 
The profile as shown by the TLC-autoradiograms indicates 
that metabolism of [HC]AA into radioactive metabolites which 
are chromatographically similar to 12-HETE and LTB, is 
localized in soluble HSS fractions from the clinically involved 
psoriatic epidermis. Only minimal activity was discernable in 
the HS particulate fraction. The transformation of [1'C]AA 
into 12-HETE by the homogenates from normal, psoriatic 
uninvolved and involved epidermis have previously been re-
ported [10]. 
Comparison of "C-labeled lipoxygenase products by HSS from 
normal, uninvolved, and involved psoriatic epidermis: To rule 
out that the observed 5-lipoxygenase-like activity in the clini-
cally involved (I) epidermis was due solely to contamination by 
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infiltrating polymorphonuclear cells, we investigated similar 
transformations of [' ''C]AA by subcellular fractions prepared 
from epidermal specimens taken from normal (N) individuals 
as well from uninvolved (U) psoriatic subjects. In preliminary 
experiments with the 3 subcellular fractions, transformation of 
( 14 C]AA into 14C-labeled lipoxygenase products was mainly 
associated with the HSS fractions ofthe normal and uninvolved 
psoriatic epidermis. Consequently, all studies to compare the 3 
enzyme sources were carried out by incubating [14C]AA with 
HSS preparations from normal (N), uninvolved (U), and clin-
ically involved (I) psoriatic epidermis. A comparison of the 
autoradiographic profiles of TLCs of these incubations with 
['"C]AA is shown in Fig 2. Strong dark bands indicating an 
enhanced metabolism of [' ''C]AA into several 14C-labeled lipox-
ygenase products by the clinically involved (I) psoriatic prepa-
ration was evident as revealed in the left lane of the TLC when 
compared to the uninvolved (middle lane) and normal (right 
lane) preparations. Moderate to low dark bands of '"C-labeled 
metaboJjtes which comigrated with authentic 12-HETE and 
L TB" were also discernable in the uninvolved and normal TLC 
lanes. Transformation of the [' ''C]AA into the ' ''C-labeled li-
poxygenase products was inhibited by ETYA (50 J.LM) and 
NDGA (30 JLM) as previously reported (5]. 
To determine the nature of the polar 14C metabolites that 
comigrated with L TB4 on TLC plates, a portion of the 14 C 
extract which contained reference standards ofLTR, and PGB2 
was subjected first to column chromatography on activated 
silicic acid as reported previously [5]. The third ethyl acetate 
eluent which contained '''C metabolite and authentic L TB, was 
dried under N2 gas and then methylated in diazomethane-ether 
solution. The resulting methyl esters of L TB,, PGB2 , and the 
14C metabolites were injected into a NP HPLC column and 
chromatographed as described under Materials and Methods. 
In a typical run, the HPLC profile of methyl esters of PGB2 
and L TB. monitored at 280 nm is shown at the top of Fig 3. 
PSORIATIC UNINVOLVED NORMAL 
FIG 2. Autoradiograph of TLCs of [14C]AA incubations with HSS 
(105,000 g) fractions from normal [N], uninvolved [U] and clinically 
involved [I] human epidermis. HSS from normal, uninvolved and 
involved epidermis (1100 11g protein) were incubated, respectively, with 
[ 14C]AA (5.8 X 105 cpm) Ca2+ (1.5 mM) , and GSH (1.0 mM). Separations 
of radiometabolites and their identification by autoradiography were 
as reported in the legend for Fig 1. Lane 1 (left) represents the 14C 
metabolites formed by the [I) psoriatic preparation; Lane 2 (middle) 
represents "C metabolites formed by the [U] preparations; Lane 3 
(right) represents 14C metabolites formed by the [N] preparations. 
Dec. 1984 BIOSYNTHESIS OF LTB,,-LIKE EICOSANOID BY PSORIATIC ENZYME PREPARATIONS 429 
0 
"' 
"' .. 
Cl 
w~ 
:r"' 
c._l 4 
-ctO 
a: -
(!) K 
o~ 
~ ~ 2 
::::;; u 
0 
a: 
:r 
<-> 
4 B 
0 4 8 
PGBz 
I 2 16 20 24 
RETENTION TIME (min) 
12 16 20 24 
ELUTION TIME (min) 
FIG 3. NP HPLC of 14C metabolites and authentic L'l'B, methyl 
esters elu ted by ethyl-acetate from silicic ac id column. HSS from 
involved [I] psoriatic epidermis (1100 l'g protein) were incubated with 
[ 14 C )AA (5.8 x 10" cpm) in the presence of Ca2+ (1.5 mM) and GSH 
( 1.0 mM). Extraction and chromatography of the 1"1C-Iabeled incubation 
extracts on silicic acid packed columns were as described under Mate-
rials and Methods. Authentic L TB.1 and PGB2 were added to the ethyl 
acetate eluent as described in the text and the mixture methylated with 
diethyl ether-diazomethane solution . Chromatography of the nonra-
dioactive methyl esters of LTB, and PGB2 as well as the methyl esters 
of the 14C metabolites was achieved by NP HPLC. The methyl esters 
were eluted isocratically using a mixture of hexane-isopropyl alco-
hol:acetic acid (94:6:0.1, vjv). The flow rate was 1 ml/min while 
sequential aliquots of HPLC fractions were collected simultaneously 
and assayed for radioactivity. Top , J-IPLC profile of nonradioactive 
me thy I esters of PGB2 and L TB,; Bottom, Distribution of methyl esters 
of 14C metabolites of dihydroxy metabolites. Approximately 6% of the 
'
4 C metabolites coeluted with nonradioactive L TB, methyl ester. 
The sequential 1-ml aliquots of t he HPLC fractions assayed 
for radioactivity are shown below the UV-monitored authentic 
standards. Approximately 6% of the methylated 14C in the ethyl 
acetate eluted from the column was associated with incubations 
of the involved (I) HSS fraction and [' ·1C]AA. The "C metab-
olite eluted in fractions 18-20 from the HPLC column with the 
same retention time as standard L TB .. methyl ester (top of 
figure) . The methylation of dihydroxy-ETEs and chromatog-
raphy by this HPLC system has been shown to separate the 
methyl esters of the authentic LTB., from the nonenzymatic 
di-HETEs [8] . Thus, the cochromatography of authentic LTB. 
with the 14C metabolite from [14CJAA in 3 chromatographic 
systems-TLC, silicic acid column, as well as by HPLC after 
derivatization into its methyl esters-strongly suggests that at 
least 6% of the 1'1C eluted from the silicic acid column by t he 
ethyl acetate is chromatographically similar to LTB.,. Other 
polar methyl esters of [1'1C]dihydroxy-ETEs not similar to 
L TB 4 methyl ester were also discernable by this HPLC system. 
The identities of these radiometabolites are presently unknown. 
For an estimation of the relative amount of 1'1C-labeled 
lipoxygenase products generated, silica gel from TLC separa-
t ions of the '"C extracts from incubations of normal , unin -
volved, and involved HSS preparations were scraped and 0.5-
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FIG 4. Statistical evaluation of [14C]dihydroxy-ETEs and [1"1C]mo-
nohydroxy-ETEs biosynt.hesized by I-ISS preparations from normal, 
uninvolved, and involved psoriatic epidermis. Data were obtained from 
incubations of [ 1'1C]AA with respective HSS fractions (1100 l'g protein). 
Details of separation of the '·'C metabolites by activated si licic acid-
coated TLC plates are as described under Materials and Methods. 
Radioactive peaks were located and estimated by scanning on a Hew-
lett-Packard radio scanner and by scraping of 0.5-mm portions of gel 
into vials and counting in a scintillation counter. The results are 
expressed as percentages of chromatographed "C metabolites per mg 
of protein of added H.SS preparations. Each column represents the 
mean ± SD of duplicate results from 10 matched involved [I] and 
uninvolved [U] epidermal specimens and 8 normal [N] epidermal 
specimens. By Student's t-test, the difference between the involved [I] 
and the uninvolved [U] or normal [N] was sign ificant (p < 0.001). 
Similarly, the difference between [Ul and [N] was also significant (p 
<0.05) . 
mm portions were counted in a scintillation counter. The data 
in Fig 4 demonstrate the percent conversions of chromate-
graphed '·'C into total [' "'C]monohydroxy- and dihydroxy-ETEs 
(including L TR,) per mg of protein. The transformation of 
["C]AA into total [' ''C]dihydroxy-ETEs by t he clinically in-
volved HSS preparations is statistically higher (p < 0.001) than 
similar incubations by the normal or the uninvolved HSS 
preparations. It is of particular interest that the biosynthesis 
of [' "'C]dihydroxy-ETEs by HSS preparations from the unin-
volved psoriatic epidermis was statistically higher (p < 0.05) 
t han similar incubations with normal epidermis. Similar statis-
tical differences were observed with biosynthesis of the ['"'C] 
monohydroxy-ETEs. 
In separate experiments from 2 psoriatic subjects [' ''C]AA 
was incubated respectively with HSS fractions prepared from 
the upper 0.2-mm section of the involved psoriatic epidermis 
which contained mainly stratum corneum and spinosum and 
with the lower 0.2-mm section of the same lesion which con-
tained mainly stratum basale and spinosum. Transformation 
of ["C)AA into the [' ''C]dihydroxy-ETEs as determined by 
TLC separations was higher by preparations from the upper 
0.2-mm section of the lesion than from t he lower 0.2-mm 
section. Although these results seem interesting, the insuffi -
cient number of specimens and experiments of this type of 
study preclude any fmal conclusion on the significance of these 
data. 
DISCUSSION 
Data from t hese studies demonstrated that t he incubation of 
[' ·'C]AA with the soluble 105,000 g supernatant fraction from 
human epidermis resulted in the formation of several 1'1C-
labeled lipoxygenase products which are chromatographically 
similar to mono-HETEs and di-HETEs. Fractionation of these 
'"'C metabolites by TLC authoradiography as well as by HPLC 
with well-characterized, authentic reference lipoxygenase prod-
ucts demonstrated that at least 2 of these 14C metabolites are 
chromatographically similar to 12-HETE and L TR,. Activity 
of the 12-lipoxygenase pathway which resulted in t he genera-
tion of ['"C]12-HETE for [14C]AA was demonstrated mainly in 
the soluble HS 105,000 g fraction. The existence of the 12-
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lipoxygenase pathway in this tissue is consistent with a previous 
report by Hammarstrom et al [10] who demonstrated the 
transformation of AA into 12-HETE as well as into other PGs 
by homogenates from normal and psoriatic skin . On the other 
hand, the occurrence of [1'1C]LTB.,-like metabolite from incu-
bations with ["'C]AA by these tissue enzyme preparations is 
novel and suggests the existence of enzymes that can catalyze 
t he transformation of AA into leukotrienes via the 5-lipoxygen-
ase- like pathway in human epidermis. An in vitro cell culture 
report [11] of the synthesis of L TB.1-Iike material by cultured 
human keratinocytes has also been reported . 
A particular focus of these studies was to compare the capac-
ities of enzyme preparations from normal , uninvolved and 
clinica lly involved psoriatic epidermis to transform AA into 
lipoxygenase products. Our data demonstrate that the biosyn-
thesis of total [ 1"1C]dihydroxy-ETEs from [14 C]AA by the clin-
ically involved HSS fractions is statistically higher than either 
t he normal or the uninvolved HSS fractions (Fig 4). A portion 
of this [' ''C]dihydroxy-ETEs was demonstrated to be similar to 
L TR, in 3 chromatographic systems. This increase in [1'1C] 
L TB.,-like metabolite by preparations of involved psoriatic 
epidermis may contribute, at least in part, to reports of elevated 
levels of L TR, in chamber fluids taken from the clinically 
involved areas of psoriatic epidermis [4]. LTB" and 5-HETE 
have also been reported as the major chemotactic eicosanoids 
extracted from psoriatic scales [12] . The possibility that 5-
HETE was also biosynthesized by our enzyme preparations 
was not investigated in these studies a lthough several other 
[ 14C]mono-HETEs remain to be identified. Our observation 
does not, however, rule out the possibility that our enzyme 
preparations from the clinically involved areas of psoriatic 
epidermis may have been contaminated by enzymes from the 
infiltrating neutrophils that are found in these lesions and 
which are known to biosynthesize the leukotrienes, although 
histologic eva luations of our specimens did not reveal such 
contaminating cells. An interesting revelation from these stud-
ies, however, was the demonstration t hat the transformation 
of [' "C]AA into [' ''C]dihydroxy-ETEs by the HSS fraction 
prepared from t he uninvolved psoriatic epidermis, which do not 
contain the infiltrating cells, was statistically higher than sim-
ilar incubations with normal epidermis. These latter results 
demonstrate that enzymes that can catalyze the transformation 
of AA into leukotrienes exist in human epidermis and this 
activity was enhanced in the uninvolved epidermis of psoriatic 
subjects. The results further imply that the elevated enzyme 
activities demonstrated by preparations from the clinically 
involved epidermis of psoriatic patients cannot be due solely to 
inliltrating neutrophils. The significance of the elevated 5-
lipoxygenase- like activity in the uninvolved psoriatic epidermis 
remains to be determined. Our data, therefore, support the 
concept that the 5-lipoxygenase-like activity as demonstrated 
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by the transformation of [' ''C]AA into (1'1C]LTB4 -like metabo-
lite by a variety of chromatographic systems is very likely 
enhanced in the involved psoriatic epidermis. 
Although our data demonstrated several radioactive bands of 
lipoxygenase products by the involved HSS fraction (Fig 2), 
t he identities of several of these metabolites remained to be 
determined. More recently, employing the techniques of GC-
MS, dihydroxy-ETEs were reported in lipid extracts of lesional 
scale and of chamber fluid from abraded involved and unin-
volved sk in of psoriatic subjects (13]. The source of these 
hydroxylated fatty acids, however, remains to be clarified. The 
localization of a soluble 5-lipoxygenase-like activity in psoriatic 
epidermis offers a useful tool for further studies on the regula-
tors of this pathway. 
The authors exp ress thei r thanks to Ms. Karen Castelli for typing 
of the manuscript. 
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